Expanded Access
◀ Back SOP 507: Expanded Access document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_151’);});Edit Version: F2425 Purpose Scope Policy Procedures Content PURPOSE The Food and Drug Administration (FDA) Expanded Access Program allows the use of an investigational medical product (drug, biologic or medical device) for treatment outside of clinical trials when there are no comparable or satisfactory therapies. This policy describes the […]
Read More